Trial Profile
A study evaluating safety and efficacy of entecavir and tenofovir in adult caucasians with chronic hepatitis B in real world setting.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Jan 2017
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 19 Jan 2017 New trial record
- 11 Jan 2017 Results published in the Digestive Diseases and Sciences